Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Agena Suzuki"'
Autor:
Agena Suzuki, Akinori Hayashi, Satoshi Oda, Rei Fujishima, Naoya Shimizu, Kenta Matoba, Tomomi Taguchi, Takuya Toki, Takeshi Miyatsuka
Publikováno v:
Endocrine Journal, Vol 71, Iss 8, Pp 767-775 (2024)
The beneficial effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors in people with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) have been suggested in several reports based on serological markers,
Externí odkaz:
https://doaj.org/article/00f5eb93060f4668a8fda6c2d44d6ba1
Autor:
Tomomi Taguchi, Kaori Kimura, Agena Suzuki, Rei Fujishima, Naoya Shimizu, Ayako Hoshiyama, Tsuguto Masaki, Mitsuko Inoue, Yukiko Kato, Takebe Satomi, Koji Takano, Tasuku Imada, Shugo Sasaki, Takeshi Miyatsuka
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract ATP6AP2, also known as (pro)renin receptor, has been shown to be expressed in several tissues including pancreatic β cells. Whereas ATP6AP2 plays an important role in regulating insulin secretion in mouse pancreatic β cells, the expression
Externí odkaz:
https://doaj.org/article/a1fc9756dc1c41898174b6b5a062a3f1
Autor:
Akinori Hayashi, Kenta Matoba, Yasuhiro Ohata, Naoya Shimizu, Agena Suzuki, Satoe Fujii, Marie Sato, Koji Takano, Masayoshi Shichiri
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Background The number of dialysis patients with diabetes is currently increasing in Japan and a similar proportion worldwide. It was suggested that approximately 20% of these patients had hypoglycemia after dialysis session and most of these
Externí odkaz:
https://doaj.org/article/ee7ad02457fa4f01a35bc8bebfe3776d
Autor:
Naoya Shimizu, Akinori Hayashi, Shiori Ito, Agena Suzuki, Rei Fujishima, Kenta Matoba, Tatsuhiko Wada, Koji Takano, Masato Katagiri, Masayoshi Shichiri
Publikováno v:
Endocrine Journal. 69:597-604
The clinical utility of intermittently scanned continuous glucose monitoring (isCGM) in patients with coronavirus disease 2019 (COVID-19) is unclear. Hence, we investigated the accuracy of isCGM in COVID-19 patients during dexamethasone therapy. We e
Autor:
Akinori Hayashi, Naoya Shimizu, Agena Suzuki, Rei Fujishima, Kenta Matoba, Ibuki Moriguchi, Naoyuki Kobayashi, Takeshi Miyatsuka
Publikováno v:
Journal of Diabetes and its Complications. 37:108470
Autor:
Ibuki Moriguchi, Agena Suzuki, Kenta Matoba, Koji Takano, Akari Momozono, Naoyuki Kobayashi, Masayoshi Shichiri, Akinori Hayashi, Naoya Shimizu, Akifumi Ogawa, Tsuguto Masaki
Publikováno v:
Diabetes Care. 44:1647-1656
OBJECTIVE There is a high risk of asymptomatic hypoglycemia associated with hemodialysis (HD) using glucose-free dialysate; therefore, the inclusion of glucose in the dialysate is believed to prevent intradialytic hypoglycemia. However, the exact gly
Autor:
Agena Suzuki, Tomomi Taguchi, Yuto Yamazaki, Yuji Kamata, Hironobu Sasano, Koji Takano, Masayoshi Shichiri
Publikováno v:
Endocrine Journal. 68:857-863
Advances in imaging technology and its widespread use have increased the number of identified patients with bilateral adrenal incidentalomas. The pathology of bilateral adrenal incidentalomas is gradually elucidated by its increased frequency. Althou
Autor:
Mamiko Hitomi, Koji Takano, Yuko Kawakami, Yuji Kamata, Masayoshi Shichiri, Akinori Hayashi, Agena Suzuki, Yasuhiro Ohata
Publikováno v:
Internal Medicine
Objective In the medical treatment of Graves' disease, we sometimes encounter patients who gain weight after the onset of the disease. To estimate the energy required during the course of treatment when hyperthyroidism ameliorates, we measured the re
Publikováno v:
Endocrine journal. 69(3)
Acromegaly is often complicated by impaired glucose tolerance. The accuracy of glycated hemoglobin (HbA1c) and glycated albumin (GA) levels in representing glycemic profiles in patients with endocrine disorders, such as acromegaly, is unclear. This r
Publikováno v:
Endocrine Journal; 2022, Vol. 69 Issue 3, p225-233, 9p